REPOMED
ActiveSummary
The annual accounts of REPOMED for financial year 2025 show a net loss of 106% of total assets and of 57% of the equity at the start of that year. The 2025 annual accounts show equity of €6,170 and a net result of -€8,110. Equity is shrinking by about 62% per year and would, assuming unchanged policy, indicatively turn negative around financial year 2026. Its solvency ranks better than 85% of 201 sector peers (NACE 38, financial year 2025). The company has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 0.8% (low).
History
Acts, filings and financial milestones
16-12
Gazette deed
Registered officeRegistered-office move2 facts ▸
- Board meeting, 01-11-2024
- Registered-office move, Agoralaan A bis, 3590 Diepenbeek (Building Bioville)
About the unread acts
Of the 3 Belgian Official Gazette deeds we know for this company, 1 has been read. The other 2 have not been read yet: what they contain is neither established nor disproved here.